| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Airways Research Centre, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia.
Correspondence to: Peter G. Gibson, MBBS (Hons), Department of Respiratory and Sleep Medicine, John Hunter Hospital, Locked Bag 1 Hunter Mail Centre, Newcastle NSW 2310, Australia; e-mail: mdpgg{at}mail.newcastle.edu.au
Study objectives: To identify the characteristics of airway inflammation in persistent asthma and to examine the role of neutrophilic inflammation in noneosinophilic persistent asthma.
Methods: Nonsmoking adults (n = 56) with persistent asthma and healthy control subjects (n = 8) underwent hypertonic saline solution challenge and sputum induction. Selected sputum portions were dispersed with dithiothreitol and assayed for total cell count, cellular differential, supernatant eosinophil cationic protein (ECP), myeloperoxidase, and interleukin (IL)-8.
Results: We identified two distinct inflammatory patterns. Typical eosinophilic inflammation occurred in 41% of subjects, whereas the remainder exhibited noneosinophilic asthma (59%). Both neutrophil percentage and absolute neutrophil counts were increased in subjects with noneosinophilic asthma (64%, 283 x 106/mL) compared to eosinophilic asthma (14%, 41 x 106/mL) and control subjects (34%, 49 x 106/mL; p = 0.0001). Myeloperoxidase was elevated in both noneosinophilic (280 ng/mL) and eosinophilic groups (254 ng/mL) compared with control subjects (82 ng/mL; p = 0.002). Sputum IL-8 levels were highest in subjects with noneosinophilic asthma (45 ng/mL) compared to eosinophilic asthma (9.6 ng/mL) and control subjects (3.5 ng/mL; p = 0.0001). Neutrophils correlated with IL-8 levels (r = 0.72). ECP was highest in subjects with eosinophilic asthma (2,685 ng/mL) compared with noneosinophilic asthma (1,081 ng/mL) and control subjects (110 ng/mL; p = 0.0001).
Conclusion: Induced-sputum analysis in persistent asthma identifies two different inflammatory patterns. The most common pattern is noneosinophilic, associated with a neutrophil influx and activation, which may be mediated by IL-8 secretion. There is heterogeneity of airway inflammation in persistent asthma, which indicates differing mechanisms and may impact on treatment responses.
Key Words: asthma • eosinophil • induced sputum • inflammation • interleukin-8 • neutrophil
This article has been cited by other articles:
|
|
 |
|
  S. Siddiqui, F. Hollins, S. Saha, and C. E. Brightling Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Eur. Respir. J., December 1, 2007; 30(6): 1043 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Goldbart, J. Krishna, R. C. Li, L. D. Serpero, and D. Gozal Inflammatory Mediators in Exhaled Breath Condensate of Children With Obstructive Sleep Apnea Syndrome. Chest, July 1, 2006; 130(1): 143 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tsoumakidou, E. Papadopouli, N. Tzanakis, and N. M. Siafakas Airway Inflammation and Cellular Stress in Noneosinophilic Atopic Asthma Chest, May 1, 2006; 129(5): 1194 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Brightling Clinical Applications of Induced Sputum Chest, May 1, 2006; 129(5): 1344 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jayaram, M. M. Pizzichini, R. J. Cook, L-P. Boulet, C. Lemiere, E. Pizzichini, A. Cartier, P. Hussack, C. H. Goldsmith, M. Laviolette, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur. Respir. J., March 1, 2006; 27(3): 483 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Brightling Sputum Induction in Asthma Chest, March 1, 2006; 129(3): 503 - 504. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Simpson, R. J. Scott, M. J. Boyle, and P. G. Gibson Differential Proteolytic Enzyme Activity in Eosinophilic and Neutrophilic Asthma Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 559 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Thakkinstian, M. McEvoy, C. Minelli, P. Gibson, B. Hancox, D. Duffy, J. Thompson, I. Hall, J. Kaufman, T.-f. Leung, et al. Systematic Review and Meta-Analysis of the Association between {beta}2-Adrenoceptor Polymorphisms and Asthma: A HuGE Review Am. J. Epidemiol., August 1, 2005; 162(3): 201 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A V Kamath, I D Pavord, P R Ruparelia, and E R Chilvers Is the neutrophil the key effector cell in severe asthma? Thorax, July 1, 2005; 60(7): 529 - 530. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hakonarson, S. Thorvaldsson, A. Helgadottir, D. Gudbjartsson, F. Zink, M. Andresdottir, A. Manolescu, D. O. Arnar, K. Andersen, A. Sigurdsson, et al. Effects of a 5-Lipoxygenase-Activating Protein Inhibitor on Biomarkers Associated With Risk of Myocardial Infarction: A Randomized Trial JAMA, May 11, 2005; 293(18): 2245 - 2256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-I. Inoue, H. Takano, R. Yanagisawa, M. Sakurai, T. Ichinose, K. Sadakane, K. Hiyoshi, M. Sato, A. Shimada, M. Inoue, et al. Role of Metallothionein in Antigen-Related Airway Inflammation Experimental Biology and Medicine, January 1, 2005; 230(1): 75 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. ten Brinke, A. H. Zwinderman, P. J. Sterk, K. F. Rabe, and E. H. Bel "Refractory" Eosinophilic Airway Inflammation in Severe Asthma: Effect of Parenteral Corticosteroids Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 601 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Sjaheim, T S Halstensen, M B Lund, O Bjortuft, P A Drablos, D Malterud, and J Kongerud Airway inflammation in aluminium potroom asthma Occup. Environ. Med., September 1, 2004; 61(9): 779 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Taube, J. A. Nick, B. Siegmund, C. Duez, K. Takeda, Y.-H. Rha, J.-W. Park, A. Joetham, K. Poch, A. Dakhama, et al. Inhibition of Early Airway Neutrophilia Does Not Affect Development of Airway Hyperresponsiveness Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 837 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hazarika, M. R. Van Scott, and R. M. Lust Myocardial ischemia-reperfusion injury is enhanced in a model of systemic allergy and asthma Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1720 - H1725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.G. Gibson and J.L. Simpson The European Network For Understanding Mechanisms Of Severe Asthma study Eur. Respir. J., March 1, 2004; 23(3): 492 - 492. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cagnoni, S. Oddera, J. Giron-Michel, A. M. Riccio, S. Olsson, P. Dellacasa, G. Melioli, G. W. Canonica, and B. Azzarone CD40 on Adult Human Airway Epithelial Cells: Expression and Proinflammatory Effects J. Immunol., March 1, 2004; 172(5): 3205 - 3214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Maghni, C. Lemiere, H. Ghezzo, W. Yuquan, and J.-L. Malo Airway Inflammation after Cessation of Exposure to Agents Causing Occupational Asthma Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 367 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gabrijelcic, A. Acuna, M. Profita, A. Paterno, K.F. Chung, A.M. Vignola, and R. Rodriguez-Roisin Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression Eur. Respir. J., August 1, 2003; 22(2): 290 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.W. Reid, C. Ward, N. Wang, L. Zheng, R. Bish, B. Orsida, and E.H. Walters Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo Eur. Respir. J., June 1, 2003; 21(6): 994 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Taube, A. Dakhama, Y.-H. Rha, K. Takeda, A. Joetham, J.-W. Park, A. Balhorn, T. Takai, K. R. Poch, J. A. Nick, et al. Transient Neutrophil Infiltration After Allergen Challenge Is Dependent on Specific Antibodies and Fc{gamma}III Receptors J. Immunol., April 15, 2003; 170(8): 4301 - 4309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Popa, S. T. Holgate, and S. Salvi Cell-mediated immunity in asthma? Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): 1607 - 1607. [Full Text] [PDF]
|
|
|
|
|
|
M.M.M. Pizzichini Is sputum eosinophilia a good or poor predictor of benefit from inhaled corticosteroid therapy in asthma? Eur. Respir. J., December 1, 2002; 20(6): 1359 - 1361. [Full Text] [PDF]
|
|
|
|
|
|
P. Godon, L-P. Boulet, J-L. Malo, A. Cartier, and C. Lemiere Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids Eur. Respir. J., December 1, 2002; 20(6): 1364 - 1369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Romagnoli, I. Vachier, P. Tarodo de la Fuente, H. Meziane, C. Chavis, J. Bousquet, P. Godard, and P. Chanez Eosinophilic inflammation in sputum of poorly controlled asthmatics Eur. Respir. J., December 1, 2002; 20(6): 1370 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R H Green, C E Brightling, G Woltmann, D Parker, A J Wardlaw, and I D Pavord Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids Thorax, October 1, 2002; 57(10): 875 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Billah, N. Cooper, M. Minnicozzi, J. Warneck, P. Wang, J. A. Hey, W. Kreutner, C. A. Rizzo, S. R. Smith, S. Young, et al. Pharmacology of N-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline Carboxamide (SCH 351591), a Novel, Orally Active Phosphodiesterase 4 Inhibitor J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 127 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R A O'Donnell and A J Frew Is there more than one inflammatory phenotype in asthma? Thorax, July 1, 2002; 57(7): 566 - 568. [Full Text] [PDF]
|
|
|
|
|
|
J Douwes, P Gibson, J Pekkanen, and N Pearce Non-eosinophilic asthma: importance and possible mechanisms Thorax, July 1, 2002; 57(7): 643 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Grattendick, R. Stuart, E. Roberts, J. Lincoln, S. S. Lefkowitz, A. Bollen, N. Moguilevsky, H. Friedman, and D. L. Lefkowitz Alveolar Macrophage Activation by Myeloperoxidase . A Model for Exacerbation of Lung Inflammation Am. J. Respir. Cell Mol. Biol., June 1, 2002; 26(6): 716 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W Anees, V Huggins, I D Pavord, A S Robertson, and P S Burge Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants Thorax, March 1, 2002; 57(3): 231 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P G Gibson, M Fujimura, and A Niimi Eosinophilic bronchitis: clinical manifestations and implications for treatment Thorax, February 1, 2002; 57(2): 178 - 182. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
